Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec 21;10(3):201-202.
doi: 10.1016/j.hrcr.2023.12.008. eCollection 2024 Mar.

A rare case of flecainide-induced encephalopathy

Elisabeth A Wong  1 , Michael Wu  1
Affiliations
Case Reports

A rare case of flecainide-induced encephalopathy

Elisabeth A Wong et al. HeartRhythm Case Rep. .
No abstract available

Keywords: Antiarrhythmic drugs; Cytochrome P450; Drug-drug interaction; Encephalopathy; Flecainide.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts to disclose.

References

    1. Lynch T., Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76:391–396. - PubMed
    1. Doki K., Homma M., Kuga K., Aonuma K., Kohda Y. Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism. Br J Clin Pharmacol. 2009;68:89–96. - PMC - PubMed
    1. Roden D. Principles in pharmacogenetics. Epilepsia. 2008;42:44–48. - PubMed
    1. Tamargo J., Le Heuzey J.Y., Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015;71:549–567. - PMC - PubMed
    1. Ghika J., Goy J.J., Naegeli C., Regli F. Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy. Schweiz Arch Neurol Psychiatr. 1994;145:4–6. - PubMed

Publication types

LinkOut - more resources